Clinical Trial Detail

NCT ID NCT02989064
Title MAGE-A10c796T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adaptimmune

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma


head and neck squamous cell carcinoma

Age Groups: adult senior

No variant requirements are available.